{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:27:32Z","timestamp":1790850452867,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s13555-023-00943-x","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T07:03:03Z","timestamp":1687244583000},"page":"1423-1433","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The Role and Benefits of Dermocosmetics in Acne Management in Japan"],"prefix":"10.1007","volume":"13","author":[{"given":"Ichiro","family":"Kurokawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miwa","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Kerob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Dreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,20]]},"reference":[{"key":"943_CR1","doi-asserted-by":"crossref","unstructured":"Tanaka A, Niimi N, Takahashi M, et\u00a0al. Prevalence of skin diseases and prognosis of atopic dermatitis in primary school children in populated areas of Japan from 2010 to 2019: the Asa Study in Hiroshima, Japan. J Dermatol. 2022;49:1284\u201390.","DOI":"10.1111\/1346-8138.16577"},{"key":"943_CR2","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/1346-8138.14355","volume":"45","author":"N Hayashi","year":"2018","unstructured":"Hayashi N, Akamatsu H, Iwatsuki K, et\u00a0al. Japanese Dermatological Association Guidelines: guidelines for the treatment of acne vulgaris 2017. J Dermatol. 2018;45:898\u2013935.","journal-title":"J Dermatol"},{"key":"943_CR3","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/jdv.13579","volume":"30","author":"E Araviiskaia","year":"2016","unstructured":"Araviiskaia E, Dreno B. The role of topical dermocosmetics in acne vulgaris. J Eur Acad Dermatol Venereol. 2016;30:926\u201335.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"943_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/09546634.2019.1628173","volume":"32","author":"E Araviiskaia","year":"2021","unstructured":"Araviiskaia E, Lopez Estebaranz JL, Pincelli C. Dermocosmetics: beneficial adjuncts in the treatment of acne vulgaris. J Dermatolog Treat. 2021;32:3\u201310.","journal-title":"J Dermatolog Treat"},{"key":"943_CR5","unstructured":"Varcin M KC. Focus on: cosmeceuticals-definitions, regulations and a review of the market. PMFA News. 2016;3."},{"key":"943_CR6","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1468-2494.2012.00740.x","volume":"34","author":"D Saint-Leger","year":"2012","unstructured":"Saint-Leger D. \u201cCosmeceuticals\u201d. Of men, science and laws. Int J Cosmet Sci. 2012;34:396\u2013401.","journal-title":"Int J Cosmet Sci"},{"key":"943_CR7","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/j.1365-2133.2008.08836.x","volume":"159","author":"A Gueniche","year":"2008","unstructured":"Gueniche A, Knaudt B, Schuck E, et\u00a0al. Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical study. Br J Dermatol. 2008;159:1357\u201363.","journal-title":"Br J Dermatol"},{"key":"943_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/jid.2013.379","volume":"134","author":"T Nakatsuji","year":"2014","unstructured":"Nakatsuji T, Gallo RL. Dermatological therapy by topical application of non-pathogenic bacteria. J Invest Dermatol. 2014;134:11\u20134.","journal-title":"J Invest Dermatol"},{"key":"943_CR9","first-page":"191","volume":"6","author":"YF Mahe","year":"2013","unstructured":"Mahe YF, Perez MJ, Tacheau C, et\u00a0al. A new Vitreoscilla filiformis extract grown on spa water-enriched medium activates endogenous cutaneous antioxidant and antimicrobial defenses through a potential Toll-like receptor 2\/protein kinase C, zeta transduction pathway. Clin Cosmet Investig Dermatol. 2013;6:191\u20136.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"943_CR10","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1080\/09546630902763164","volume":"20","author":"CL Goh","year":"2009","unstructured":"Goh CL, Tang MB, Briantais P, et\u00a0al. Adapalene gel 0.1% is better tolerated than tretinoin gel 0.025% among healthy volunteers of various ethnic origins. J Dermatolog Treat. 2009;20:282\u20138.","journal-title":"J Dermatolog Treat"},{"key":"943_CR11","doi-asserted-by":"crossref","unstructured":"Abad-Casintahan F, Chow SK, Goh CL, et\u00a0al. Frequency and characteristics of acne-related post-inflammatory hyperpigmentation. J Dermatol. 2016;43:826\u20138.","DOI":"10.1111\/1346-8138.13263"},{"key":"943_CR12","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/1346-8138.12885","volume":"42","author":"N Hayashi","year":"2015","unstructured":"Hayashi N, Miyachi Y, Kawashima M. Prevalence of scars and \u201cmini-scars\u201d, and their impact on quality of life in Japanese patients with acne. J Dermatol. 2015;42:690\u20136.","journal-title":"J Dermatol"},{"key":"943_CR13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2147\/CCID.S359055","volume":"15","author":"P Boonchaya","year":"2022","unstructured":"Boonchaya P, Rojhirunsakool S, Kamanamool N, et\u00a0al. Minimum contact time of 1.25%, 2.5%, 5%, and 10% benzoyl peroxide for a bactericidal effect against Cutibacterium acnes. Clin Cosmet Investig Dermatol. 2022;15:403\u20139.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"943_CR14","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1684\/ejd.2018.3367","volume":"28","author":"J Tan","year":"2018","unstructured":"Tan J, Bissonnette R, Gratton D, et\u00a0al. The safety and efficacy of four different fixed combination regimens of adapalene 0.1%\/benzoyl peroxide 2.5% gel for the treatment of acne vulgaris: results from a randomised controlled study. Eur J Dermatol. 2018;28:502\u20138.","journal-title":"Eur J Dermatol"},{"key":"943_CR15","unstructured":"Data on file. La Roche Posay 2022."},{"issue":"Suppl 5","key":"943_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/jdv.14374","volume":"31","author":"B Dreno","year":"2017","unstructured":"Dreno B. What is new in the pathophysiology of acne, an overview. J Eur Acad Dermatol Venereol. 2017;31(Suppl 5):8\u201312.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"943_CR17","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/exd.14467","volume":"31","author":"MA Dagnelie","year":"2022","unstructured":"Dagnelie MA, Corvec S, Timon-David E, et\u00a0al. Cutibacterium acnes and Staphylococcus epidermidis: the unmissable modulators of skin inflammatory response. Exp Dermatol. 2022;31:406\u201312.","journal-title":"Exp Dermatol"},{"key":"943_CR18","first-page":"SF3502915-SF350","volume":"21","author":"J Marson","year":"2022","unstructured":"Marson J, Bhatia N, Graber E, et\u00a0al. The role of epidermal barrier dysfunction and cutaneous microbiome dysbiosis in the pathogenesis and management of acne vulgaris and rosacea. J Drugs Dermatol. 2022;21:SF3502915\u201335029114.","journal-title":"J Drugs Dermatol"},{"key":"943_CR19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/BF01262335","volume":"287","author":"A Yamamoto","year":"1995","unstructured":"Yamamoto A, Takenouchi K, Ito M. Impaired water barrier function in acne vulgaris. Arch Dermatol Res. 1995;287:214\u20138.","journal-title":"Arch Dermatol Res"},{"key":"943_CR20","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/exd.13499","volume":"27","author":"A Pappas","year":"2018","unstructured":"Pappas A, Kendall AC, Brownbridge LC, et\u00a0al. Seasonal changes in epidermal ceramides are linked to impaired barrier function in acne patients. Exp Dermatol. 2018;27:833\u20136.","journal-title":"Exp Dermatol"},{"key":"943_CR21","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/1346-8138.14314","volume":"45","author":"JA See","year":"2018","unstructured":"See JA, Goh CL, Hayashi N, et\u00a0al. Optimizing the use of topical retinoids in Asian acne patients. J Dermatol. 2018;45:522\u20138.","journal-title":"J Dermatol"},{"key":"943_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s41232-022-00212-y","volume":"42","author":"Y Ito","year":"2022","unstructured":"Ito Y, Amagai M. Controlling skin microbiome as a new bacteriotherapy for inflammatory skin diseases. Inflamm Regen. 2022;42:26.","journal-title":"Inflamm Regen"},{"key":"943_CR23","first-page":"SF3502913-SF4","volume":"21","author":"J Marson","year":"2022","unstructured":"Marson J, Baldwin H. Dysbiosis, (barrier) dysfunction, and dermatoses: a chicken-and-egg dilemma. J Drugs Dermatol. 2022;21:SF3502913\u20134.","journal-title":"J Drugs Dermatol"},{"key":"943_CR24","doi-asserted-by":"crossref","unstructured":"Lee YB, Byun EJ, Kim HS. Potential role of the microbiome in acne: a comprehensive review. J Clin Med 2019;8(7):987.","DOI":"10.3390\/jcm8070987"},{"key":"943_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s40257-020-00531-1","volume":"21","author":"B Dreno","year":"2020","unstructured":"Dreno B, Dagnelie MA, Khammari A, et\u00a0al. The skin microbiome: a new actor in inflammatory acne. Am J Clin Dermatol. 2020;21:18\u201324.","journal-title":"Am J Clin Dermatol"},{"key":"943_CR26","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1038\/jid.2013.21","volume":"133","author":"S Fitz-Gibbon","year":"2013","unstructured":"Fitz-Gibbon S, Tomida S, Chiu BH, et\u00a0al. Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Invest Dermatol. 2013;133:2152\u201360.","journal-title":"J Invest Dermatol"},{"key":"943_CR27","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1111\/jdv.15795","volume":"33","author":"MA Dagnelie","year":"2019","unstructured":"Dagnelie MA, Corvec S, Saint-Jean M, et\u00a0al. Cutibacterium acnes phylotypes diversity loss: a trigger for skin inflammatory process. J Eur Acad Dermatol Venereol. 2019;33:2340\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"943_CR28","doi-asserted-by":"publisher","first-page":"31968","DOI":"10.1038\/srep31968","volume":"6","author":"E Barnard","year":"2016","unstructured":"Barnard E, Liu J, Yankova E, et\u00a0al. Strains of the Propionibacterium acnes type III lineage are associated with the skin condition progressive macular hypomelanosis. Sci Rep. 2016;6:31968.","journal-title":"Sci Rep"},{"key":"943_CR29","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/phpp.12411","volume":"34","author":"Z Wang","year":"2018","unstructured":"Wang Z, Choi JE, Wu CC, et\u00a0al. Skin commensal bacteria Staphylococcus epidermidis promote survival of melanocytes bearing UVB-induced DNA damage, while bacteria Propionibacterium acnes inhibit survival of melanocytes by increasing apoptosis. Photodermatol Photoimmunol Photomed. 2018;34:405\u201314.","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"943_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/BF01833872","volume":"23","author":"HC Korting","year":"1995","unstructured":"Korting HC, Ponce-Poschl E, Klovekorn W, et\u00a0al. The influence of the regular use of a soap or an acidic syndet bar on pre-acne. Infection. 1995;23:89\u201393.","journal-title":"Infection"},{"key":"943_CR31","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1159\/000094670","volume":"19","author":"MH Schmid-Wendtner","year":"2006","unstructured":"Schmid-Wendtner MH, Korting HC. The pH of the skin surface and its impact on the barrier function. Skin Pharmacol Physiol. 2006;19:296\u2013302.","journal-title":"Skin Pharmacol Physiol"},{"key":"943_CR32","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/jdv.12757","volume":"29","author":"B Dreno","year":"2015","unstructured":"Dreno B, Thiboutot D, Layton AM, et\u00a0al. Large-scale international study enhances understanding of an emerging acne population: adult females. J Eur Acad Dermatol Venereol. 2015;29:1096\u2013106.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"943_CR33","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1159\/000151441","volume":"217","author":"M Jones-Caballero","year":"2008","unstructured":"Jones-Caballero M, Pedrosa E, Penas PF. Self-reported adherence to treatment and quality of life in mild to moderate acne. Dermatology. 2008;217:309\u201314.","journal-title":"Dermatology"},{"key":"943_CR34","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1177\/0300060519847367","volume":"47","author":"DB Sevimli","year":"2019","unstructured":"Sevimli DB. Topical treatment of acne vulgaris: efficiency, side effects, and adherence rate. J Int Med Res. 2019;47:2987\u201392.","journal-title":"J Int Med Res"},{"key":"943_CR35","first-page":"161","volume":"153","author":"MV Cannizzaro","year":"2018","unstructured":"Cannizzaro MV, Dattola A, Garofalo V, et\u00a0al. Reducing the oral isotretinoin skin side effects: efficacy of 8% omega-ceramides, hydrophilic sugars, 5% niacinamide cream compound in acne patients. G Ital Dermatol Venereol. 2018;153:161\u20134.","journal-title":"G Ital Dermatol Venereol"},{"key":"943_CR36","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3109\/09546634.2015.1079298","volume":"27","author":"L Chularojanamontri","year":"2016","unstructured":"Chularojanamontri L, Tuchinda P, Kulthanan K, et\u00a0al. A double-blinded, randomized, vehicle-controlled study to access skin tolerability and efficacy of an anti-inflammatory moisturizer in treatment of acne with 0.1% adapalene gel. J Dermatolog Treat. 2016;27:140\u20135.","journal-title":"J Dermatolog Treat"},{"key":"943_CR37","unstructured":"Draelos ZD BN, Colon G, Dreno B. The effect of ceramide-containing skincare on acne medication-induced barrier dysfunction. Eur Acad Dermatol Venereol. 2021."},{"key":"943_CR38","first-page":"1104","volume":"11","author":"ES Schorr","year":"2012","unstructured":"Schorr ES, Sidou F, Kerrouche N. Adjunctive use of a facial moisturizer SPF 30 containing ceramide precursor improves tolerability of topical tretinoin 0.05%: a randomized, investigator-blinded, split-face study. J Drugs Dermatol. 2012;11:1104\u20137.","journal-title":"J Drugs Dermatol"},{"key":"943_CR39","unstructured":"Kerob D, Demessant AL, LeDantec G, et\u00a0al. Benefits of a dermocosmetic regime in the management of local cutaneous intolerance induced by a gel based on retinoids for acne, previously mitigated inadequately, with adjunct routine skin care. In: RADLA: Reunion Anual de Dermatologos Latinoamericanos. Chile, virtual; 2022."},{"key":"943_CR40","first-page":"22","volume":"8","author":"JQ Del Rosso","year":"2015","unstructured":"Del Rosso JQ, Gold M, Rueda MJ, et\u00a0al. Efficacy, safety, and subject satisfaction of a specified skin care regimen to cleanse, medicate, moisturize, and protect the skin of patients under treatment for acne vulgaris. J Clin Aesthet Dermatol. 2015;8:22\u201330.","journal-title":"J Clin Aesthet Dermatol"},{"key":"943_CR41","first-page":"26","volume":"153","author":"G Monfrecola","year":"2018","unstructured":"Monfrecola G, Capasso C, Russo G, et\u00a0al. UV-selective face cream (Acne RA-1,2) in acne patients: clinical study of its effects on epidermal barrier function, sebum production, tolerability and therapy adherence. G Ital Dermatol Venereol. 2018;153:26\u201332.","journal-title":"G Ital Dermatol Venereol"},{"key":"943_CR42","first-page":"748","volume":"11","author":"JA Zeichner","year":"2012","unstructured":"Zeichner JA, Patel RV, Haddican M, et\u00a0al. Efficacy and safety of a ceramide containing moisturizer followed by fixed-dose clindamycin phosphate 1.2%\/benzoyl peroxide 2.5% gel in the morning in combination with a ceramide containing moisturizer followed by tretinoin 0.05% gel in the evening for the treatment of facial acne vulgaris. J Drugs Dermatol. 2012;11:748\u201352.","journal-title":"J Drugs Dermatol"},{"key":"943_CR43","doi-asserted-by":"crossref","unstructured":"Dreno B, Khammari A, Duhamel K, et\u00a0al. A dermocosmetic associated with a fixed combination of adapalene 0.1% and benzoyl peroxide 5% helps to protect the skin barrier in mild to moderate acne. In: American Academy of Dermatology. San Francisco, CA virtual 2021.","DOI":"10.1016\/j.jaad.2021.06.394"},{"key":"943_CR44","first-page":"28","volume":"6","author":"JQ Del Rosso","year":"2013","unstructured":"Del Rosso JQ, Brandt S. The role of skin care as an integral component in the management of acne vulgaris: Part 2: tolerability and performance of a designated skin care regimen using a foam wash and moisturizer SPF 30 in patients with acne vulgaris undergoing activetreatment. J Clin Aesthet Dermatol. 2013;6:28\u201336.","journal-title":"J Clin Aesthet Dermatol"},{"key":"943_CR45","unstructured":"Tan J. In: Eur Acad Dermatol and Venereol Annual Meeting; 2022."},{"key":"943_CR46","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1177\/12034754211037994","volume":"26","author":"M Lam","year":"2022","unstructured":"Lam M, Hu A, Fleming P, et\u00a0al. The impact of acne treatment on skin bacterial microbiota: a systematic review. J Cutan Med Surg. 2022;26:93\u20137.","journal-title":"J Cutan Med Surg"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-023-00943-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-023-00943-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-023-00943-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T16:31:26Z","timestamp":1687969886000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-023-00943-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,20]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["943"],"URL":"https:\/\/doi.org\/10.1007\/s13555-023-00943-x","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,20]]},"assertion":[{"value":"14 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}